Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues - PubMed (original) (raw)
. 1990 May 25;265(15):8519-24.
Affiliations
- PMID: 2341393
Free article
Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues
T Mizuochi et al. J Biol Chem. 1990.
Free article
Abstract
The N-linked oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 derived from chronically infected lymphoblastoid (H9) cells have been investigated by enzymatic microsequencing after release from protein by hydrazinolysis, labeling with NaB3H4, and chromatography on adsorbent columns of Phaseolus vulgaris erythrophytohemagglutinin and Ricinus communis agglutinin (Mr 120,000) and on Bio-Gel P-4. A substantially greater diversity of oligosaccharide structures was detected than among those released by hydrazinolysis from recombinant gp120 produced in Chinese hamster ovary cells and investigated by similar procedures (Mizuochi, T., Spellman, M.W., Larkin, M., Solomon, J., Basa, L.J., and Feizi, T. (1988) Biochem J. 254, 599-603) and among those released by endoglycosidases from virus-derived gp120 isolated from infected H9 cells after metabolic labeling with D-[2-3H]mannose or D-[6-3H]glucosamine (Geyer, H., Holschbach, L., Hunsmann, G., and Schneider, J. (1988) J. Biol. Chem. 263, 11760-11767). In this study, 16% of the oligosaccharides were identified as complex-type bi-, tri-, and tetraantennary sialo-oligosaccharides with bisecting N-acetylglucosamine residues. Such structures were lacking on recombinant gp120 and could not be detected on the metabolically labeled, virus-derived glycoprotein. As in the earlier investigations, complex-type chains lacking bisecting N-acetylglucosamine residues, hybrid-type chains, and a series of high mannose-type structures with 5-9 mannose residues were identified. In addition, an array of complex-type chains having one or more outer chains with beta-galactosyl residues were detected in this study, but with additional substitutions that require further investigation. The number of potential N-glycosylation sites on gp120 is on the order of 20, but the oligosaccharide structures are far more numerous. Thus, the salient conclusion from this and earlier investigations is that alternative structures occur on at least some of the glycosylation sites and that numerous glycosylation variants of this glycoprotein are produced even within a single cell line. Since the glycosylation is the product of host cell glycosyltransferases, an even greater number of glycosylation variants of gp120 are predicted to arise from the heterogeneous cell populations harboring the virus in in vivo infection.
Similar articles
- Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells.
Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T. Mizuochi T, et al. Biochem J. 1988 Sep 1;254(2):599-603. doi: 10.1042/bj2540599. Biochem J. 1988. PMID: 2845957 Free PMC article. - [New anti-HIV drug which binds the oligosaccharides of HIV envelope glycoprotein].
Mizuochi T, Nakata M. Mizuochi T, et al. Nihon Rinsho. 1995 Sep;53(9):2340-9. Nihon Rinsho. 1995. PMID: 7474402 Review. Japanese.
Cited by
- Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
Galili U. Galili U. Med Res Arch. 2021 Jul;9(7):2481. doi: 10.18103/mra.v9i7.2481. Epub 2021 Jul 10. Med Res Arch. 2021. PMID: 34853815 Free PMC article. - Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.
Galili U. Galili U. Vaccine. 2020 Sep 29;38(42):6487-6499. doi: 10.1016/j.vaccine.2020.08.032. Epub 2020 Aug 19. Vaccine. 2020. PMID: 32907757 Free PMC article. Review. - Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.
Ohyama Y, Nakajima K, Renfrow MB, Novak J, Takahashi K. Ohyama Y, et al. Expert Rev Proteomics. 2020 Apr;17(4):275-296. doi: 10.1080/14789450.2020.1769479. Epub 2020 May 28. Expert Rev Proteomics. 2020. PMID: 32406805 Free PMC article. Review. - Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans.
Wu NR, Nicely NI, Lee EM, Reed RK, Watts BE, Cai F, Walkowicz WE, Aussedat B, Jones JA, Eaton A, Trama AM, Alam SM, Montefiori DC, Haynes BF, Saunders KO. Wu NR, et al. PLoS Pathog. 2019 Dec 16;15(12):e1008165. doi: 10.1371/journal.ppat.1008165. eCollection 2019 Dec. PLoS Pathog. 2019. PMID: 31841553 Free PMC article. - Glycopeptides and -Mimetics to Detect, Monitor and Inhibit Bacterial and Viral Infections: Recent Advances and Perspectives.
Behren S, Westerlind U. Behren S, et al. Molecules. 2019 Mar 13;24(6):1004. doi: 10.3390/molecules24061004. Molecules. 2019. PMID: 30871155 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials